These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 22290956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.
    Lahiri Mukhopadhyay S, Bahubali VH, Manjunath N, Swaminathan A, Maji S, Palaniappan M, Parthasarathy S, Chandrashekar N.
    Mycoses; 2017 Nov; 60(11):749-757. PubMed ID: 28736880
    [Abstract] [Full Text] [Related]

  • 23. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
    Soares BM, Santos DA, Kohler LM, da Costa César G, de Carvalho IR, dos Anjos Martins M, Cisalpino PS.
    Rev Iberoam Micol; 2008 Dec 31; 25(4):242-5. PubMed ID: 19071894
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
    Gast CE, Basso LR, Bruzual I, Wong B.
    Antimicrob Agents Chemother; 2013 Nov 31; 57(11):5478-85. PubMed ID: 23979758
    [Abstract] [Full Text] [Related]

  • 26. In vitro susceptibility of Cryptococcus gattii clinical isolates.
    Gomez-Lopez A, Zaragoza O, Dos Anjos Martins M, Melhem MC, Rodriguez-Tudela JL, Cuenca-Estrella M.
    Clin Microbiol Infect; 2008 Jul 31; 14(7):727-30. PubMed ID: 18558948
    [Abstract] [Full Text] [Related]

  • 27. Punicalagin triggers ergosterol biosynthesis disruption and cell cycle arrest in Cryptococcus gattii and Candida albicans : Action mechanisms of punicalagin against yeasts.
    Silva TC, de Ávila RI, Zara ALSA, Santos AS, Ataídes F, Freitas VAQ, Costa CR, Valadares MC, Silva MDRR.
    Braz J Microbiol; 2020 Dec 31; 51(4):1719-1727. PubMed ID: 32856241
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.
    Chitty JL, Butler MS, Suboh A, Edwards DJ, Cooper MA, Fraser JA, Robertson AAB.
    Antimicrob Agents Chemother; 2018 Feb 31; 62(2):. PubMed ID: 29158283
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: Global antifungal antimicrobial testing leadership and surveillance program, 2010-2020.
    Jean SS, Liu CY, Huang YT, Ko WC, Ho MW, Liu IM, Hsieh PC, Hsueh PR.
    Int J Antimicrob Agents; 2024 Mar 31; 63(3):107090. PubMed ID: 38242250
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H.
    Mycoses; 2006 Jul 31; 49(4):324-30. PubMed ID: 16784448
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J.
    Antimicrob Agents Chemother; 2012 Nov 31; 56(11):5898-906. PubMed ID: 22948877
    [Abstract] [Full Text] [Related]

  • 38. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
    Bastos RW, Carneiro HCS, Oliveira LVN, Rocha KM, Freitas GJC, Costa MC, Magalhães TFF, Carvalho VSD, Rocha CE, Ferreira GF, Paixão TA, Moyrand F, Janbon G, Santos DA.
    Antimicrob Agents Chemother; 2018 Jan 31; 62(1):. PubMed ID: 29109169
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.